S. Lafon

发表

Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients.

R. Baughman, M. Dohn, M. Rogers, 1991, The Journal of protozoology.

Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.

D. Nelson, R. L. Berens, J. Marr, 1984, The Journal of infectious diseases.

Inosine analogs as chemotherapeutic agents for African trypanosomes: metabolism in trypanosomes and efficacy in tissue culture

D. Nelson, A. Balber, R. L. Berens, 1985, Antimicrobial Agents and Chemotherapy.

Purine and pyrimidine salvage pathways in Leishmania donovani.

D. Nelson, R. L. Berens, J. Marr, 1982, Biochemical pharmacology.

Atovaquone Suspension in HIV‐Infected Volunteers: Pharmacokinetics, Pharmacodynamics, and TMP‐SMX Interaction Study

R. Davey, J. Kovacs, M. Polis, 1999, Pharmacotherapy.

Mutations in HIV-1 Reverse Transcriptase during Therapy with Abacavir, Lamivudine and Zidovudine in HIV-1-Infected Adults with No Prior Antiretroviral Therapy

M. Fischl, N. Clumeck, M. Ait-Khaled, 2002, Antiviral therapy.

Safety and Pharmacokinetics of Abacavir (1592U89) following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

S. Hetherington, Y. Lou, S. Lafon, 1999, Antimicrobial Agents and Chemotherapy.

Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation.

R. Miller, D. Nelson, R. L. Berens, 1979, The Journal of biological chemistry.

Inosine analogs. Their metabolism in mouse L cells and in Leishmania donovani.

D. Nelson, R. L. Berens, J. Marr, 1985, The Journal of biological chemistry.

Purine metabolism in Trypanosoma cruzi.

D. Nelson, R. L. Berens, J. Marr, 1981, Molecular and biochemical parasitology.

Antileishmanial effect of allopurinol and allopurinol ribonucleoside on intracellular forms of Leishmania donovani.

D. Nelson, R. L. Berens, J. Marr, 1980, Biochemical pharmacology.

Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism.

D. Nelson, T. Spector, R. L. Berens, 1982, Biochemical pharmacology.

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.

D. O'neill, R. Davey, J. Kovacs, 1991, The New England journal of medicine.

Purine metabolism in the intact sporozoites and merozoites of Eimeria tenella.

D. Nelson, S. Lafon, 1985, Molecular and biochemical parasitology.

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV‐infected adults

R. Schooley, B. Gazzard, M. Saag, 1998, AIDS.

The metabolism of formycin B in Leishmania donovani.

D. Nelson, T. Spector, R. L. Berens, 1982, Biochemical and biophysical research communications.

Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.

H. Masur, W. Hughes, S. Lafon, 1995, The Journal of infectious diseases.

Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity.

S. Vogel, J. Falloon, H. Masur, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antiprotozoal activity of 3'-deoxyinosine. Inverse correlation to cleavage of the glycosidic bond.

D. Nelson, R. L. Berens, J. Marr, 1991, Biochemical pharmacology.

Use of Drug Effect Interaction Modeling with Monte Carlo Simulation To Examine the Impact of Dosing Interval on the Projected Antiviral Activity of the Combination of Abacavir and Amprenavir

J. Bilello, G. Drusano, M. Rogers, 2000, Antimicrobial Agents and Chemotherapy.

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.

O. Naderer, G. Pearce, H. Steel, 2001, Clinical therapeutics.

6-Thiopurine riboside analogs: their toxicity and metabolism in Leishmania donovani and mammalian cells.

D. Nelson, R. L. Berens, N. Cohn, 1985 .

Prophylactically administered Retrovir in health care workers potentially exposed to the human immunodeficiency virus.

D. Barry, S. Lehrman, S. Lafon, 1988, The Journal of infectious diseases.

Monophosphates of formycin B and allopurinol riboside. Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase.

D. Nelson, T. Spector, R. L. Berens, 1984, Biochemical pharmacology.

Antigiardial activity of guanine arabinoside. Mechanism studies.

R. Miller, D. Nelson, T. Krenitsky, 1987, Biochemical pharmacology.

Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia.

E. Pattishall, M. Rogers, W. Hughes, 1998, The Journal of infectious diseases.

Antiviral Efficacy of Abacavir in Antiretroviral Therapy-Experienced Adults Harbouring HIV-1 with Specific Patterns of Resistance to Nucleoside Reverse Transcriptase Inhibitors

S. Hetherington, G. Pearce, W. Spreen, 2004, Antiviral therapy.

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.

J. Falloon, H. Masur, S. Bozzette, 1993, The New England journal of medicine.